{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:08:39Z","timestamp":1769749719222,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.arcped.2013.04.013","type":"journal-article","created":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T15:48:34Z","timestamp":1373644114000},"page":"762-767","source":"Crossref","is-referenced-by-count":12,"title":["Efficacit\u00e9 des empl\u00e2tres de lidoca\u00efne 5\u00a0% sur les douleurs des crises vaso-occlusives chez l\u2019enfant dr\u00e9panocytaire"],"prefix":"10.1016","volume":"20","author":[{"given":"J.","family":"Rasolofo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Poncelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Marec-Berard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2013.04.013_bib0005","unstructured":"HAS. Recommandations pour la pratique clinique\u00a0\u2013\u00a0Prise en charge de la dr\u00e9panocytose chez l\u2019enfant et l\u2019adolescent. Haute Autorit\u00e9 de sant\u00e9. Septembre 2005. http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/Drepanocytose_reco.pdf."},{"key":"10.1016\/j.arcped.2013.04.013_bib0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/asheducation-2010.1.409","article-title":"Sickle cell disease: advances in epidemiology and etiology","volume":"2010","author":"Smith","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.arcped.2013.04.013_bib0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/s0304-3959(02)00374-3","article-title":"Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease","volume":"102","author":"Jacob","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.arcped.2013.04.013_bib0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0027-9684(15)30471-5","article-title":"Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease","volume":"102","author":"Wilkie","year":"2010","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.arcped.2013.04.013_bib0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/03630269.2011.610478","article-title":"Update on pain management in sickle cell disease","volume":"35","author":"Ballas","year":"2011","journal-title":"Hemoglobin"},{"key":"10.1016\/j.arcped.2013.04.013_bib0030","unstructured":"HAS Commission de transparence HAS 6\u00a0octobre 2010. http:\/\/www.has-sante.fr\/portail\/jcms\/c_987733\/fr\/commission-de-la-transparence-reunion-du-6-octobre-2010."},{"key":"10.1016\/j.arcped.2013.04.013_bib0035","first-page":"3","article-title":"Les douleurs neuropathiques chroniques\u00a0: diagnostic, \u00e9valuation et traitement en m\u00e9decine ambulatoire. Recommandations pour la pratique clinique de la Soci\u00e9t\u00e9 fran\u00e7aise d\u2019\u00e9tude et de traitement de la douleur","volume":"11","author":"Martinez","year":"2010","journal-title":"Douleurs"},{"key":"10.1016\/j.arcped.2013.04.013_bib0040","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.arcped.2011.05.016","article-title":"Prise en charge des douleurs neuropathiques chez l\u2019enfant\u00a0: recommandations de bonne pratique clinique","volume":"18","author":"Fournier-Charri\u00e8re","year":"2011","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2013.04.013_bib0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.arcped.2013.04.013_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3959(95)00146-8","article-title":"Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. BS","volume":"65","author":"Rowbotham","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.arcped.2013.04.013_bib0055","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2165\/11203220-000000000-00000","article-title":"Lidocaine 5% medicated plaster: a review of its use in post-herpetic neuralgia","volume":"69","author":"Garnock-Jones","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.arcped.2013.04.013_bib0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0091270002239817","article-title":"Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature","volume":"43","author":"Gammaitoni","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.arcped.2013.04.013_bib0065","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1460-9592.2008.02491.x","article-title":"Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases","volume":"18","author":"Nayak","year":"2008","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.arcped.2013.04.013_bib0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1085\/jgp.20028651","article-title":"Molecular action of lidocaine on the voltage sensors of sodium channels","volume":"121","author":"Sheets","year":"2003","journal-title":"Gen Physiol"},{"key":"10.1016\/j.arcped.2013.04.013_bib0075","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0705796","article-title":"Differential modulation of Nav 1.7\u00a0and Nav 1.8\u00a0peripheral nerve sodium channels by the local anesthetic lidocaine","volume":"142","author":"Chevrier","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.arcped.2013.04.013_bib0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00000539-200101000-00025","article-title":"The effects of lidocaine on nitric oxide production from an activated murine macrophage cell line","volume":"92","author":"Shiga","year":"2001","journal-title":"Anesth Analg"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X13002911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X13002911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T03:29:05Z","timestamp":1563420545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X13002911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0929693X13002911"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2013.04.013","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}